Patents by Inventor Steve M. Watkins

Steve M. Watkins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9810697
    Abstract: The invention relates to biomarkers associated with Diabetes, including protein and lipid metabolite biomarkers, methods of using the biomarkers to determine the risk that an individual will develop Diabetes, and methods of screening a population to identify persons at risk for developing Diabetes and other pre-diabetic conditions.
    Type: Grant
    Filed: November 18, 2015
    Date of Patent: November 7, 2017
    Assignee: True Health IP, LLC
    Inventors: Michael P. McKenna, Steve M. Watkins
  • Publication number: 20170003297
    Abstract: The invention relates to biomarkers associated with Diabetes, including protein and lipid metabolite biomarkers, methods of using the biomarkers to determine the risk that an individual will develop Diabetes, and methods of screening a population to identify persons at risk for developing Diabetes and other pre-diabetic conditions.
    Type: Application
    Filed: November 18, 2015
    Publication date: January 5, 2017
    Inventors: Michael P. McKenna, Steve M. Watkins
  • Patent number: 9217747
    Abstract: The invention relates to biomarkers associated with Diabetes, including protein and lipid metabolite biomarkers, methods of using the biomarkers to determine the risk that an individual will develop Diabetes, and methods of screening a population to identify persons at risk for developing Diabetes and other pre-diabetic conditions.
    Type: Grant
    Filed: October 28, 2010
    Date of Patent: December 22, 2015
    Assignee: Health Diagnostic Laboratory, Inc.
    Inventors: Michael P. McKenna, Steve M. Watkins
  • Publication number: 20120328594
    Abstract: The invention relates to biomarkers associated with Diabetes, including protein and lipid metabolite biomarkers, methods of using the biomarkers to determine the risk that an individual will develop Diabetes, and methods of screening a population to identify persons at risk for developing Diabetes and other pre-diabetic conditions.
    Type: Application
    Filed: October 28, 2010
    Publication date: December 27, 2012
    Applicant: TETHYS BIOSCIENCE, INC.
    Inventors: Michael P. McKenna, Steve M. Watkins
  • Publication number: 20110172926
    Abstract: This disclosure provides methods for the creation of a quantitative database of metabolites, particularly lipid metabolites, using chromatographic technology; methods for assembling that information into a visual format for interpretation, and methods of this information to identify and understand metabolome-wide effects, for instance those effects influenced by pharmaceuticals, genes, toxins, diet or the environment. Also provided are metabolite databases, such as lipid metabolite databases, that are stored on a computer readable medium, which include quantitative measurements of a plurality of metabolites.
    Type: Application
    Filed: June 3, 2009
    Publication date: July 14, 2011
    Applicant: TETHYS BIOSCIENCE, INC.
    Inventor: Steve M. Watkins
  • Publication number: 20090221081
    Abstract: The present invention provides methods of using certain metabolite markers for predicting weight development or its related conditions of a subject. The present invention also provides compositions and kits useful for detecting metabolite markers of the present invention.
    Type: Application
    Filed: November 26, 2008
    Publication date: September 3, 2009
    Inventors: Steve M. Watkins, Michelle M. Wiest